| J9271 | Injection, pembrolizumab, 1 mg | 250 | $9,030 | $2.2M |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 810 | $1,390 | $1.1M |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 9,520 | $90 | $847.6K |
| J1459 | Injection, immune globulin (privigen), intravenous, non-lyophilized (e.g., liquid), 500 mg | 460 | $1,450 | $671.9K |
| 96365 | The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease. | 5,890 | $50 | $318K |
| J1439 | Injection, ferric carboxymaltose, 1 mg | 300 | $760 | $225.3K |
| 96375 | Following the administration of a drug or other substance via intravenous, or IV, push, the provider sequentially infuses a different medication or medications, also via IV push. He administers the… | 9,520 | $20 | $190.3K |
| J1569 | Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | 250 | $770 | $189.6K |
| 36430 | In this procedure, the provider punctures and places a catheter into a vein to transfuse blood or blood components directly into the patient’s bloodstream. | 1,180 | $150 | $181.9K |
| 96417 | In this add–on procedure, the provider continues administration of a chemotherapy drug into a vein using an infusion technique. He uses this code to report administration of a different chemotherapy… | 2,310 | $60 | $129.3K |